Zhang Dechun, Pei Shaoxuan, Feng Zixuan, Xia Guangfeng
Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, 330031, China.
Department of Hepatobiliary Surgery, Jiujiang University Affiliated Hospital, Jiujiang, 332000, China.
J Transl Med. 2025 Jun 19;23(1):689. doi: 10.1186/s12967-025-06732-8.
Recent studies have progressively clarified the critical role of long non-coding RNA (lncRNA) in cancer, especially concerning its involvement in immune processes, which holds significant therapeutic promise. However, the incorporation of lncRNA into immunotherapy has yet to demonstrate adequate clinical efficacy. This shortcoming can be attributed to various challenges, including unclear mechanisms of action and limited prognostic capacity. In colorectal cancer (CRC), this ineffectiveness may predominantly stem from immune escape mechanisms mediated by lncRNAs. Despite some exploration into lncRNA-driven immune escape, a comprehensive overview of its implications for immunotherapy in CRC remains inadequately addressed. In this review, we thoroughly assess the role of lncRNA in immune escape mechanisms associated with CRC, focusing on immune checkpoints, immune cells, and cytokines. We elucidate the relationship between lncRNA-mediated immune escape and CRC progression and discuss strategies for lncRNA-mediated immunotherapy for CRC. Our aim is to provide fresh insights into the potential of targeting lncRNAs to enhance the effectiveness of immunotherapeutic strategies in CRC.
最近的研究逐渐阐明了长链非编码RNA(lncRNA)在癌症中的关键作用,特别是其在免疫过程中的参与,这具有重大的治疗前景。然而,将lncRNA纳入免疫疗法尚未显示出足够的临床疗效。这一缺点可归因于各种挑战,包括作用机制不明和预后能力有限。在结直肠癌(CRC)中,这种无效可能主要源于lncRNAs介导的免疫逃逸机制。尽管对lncRNA驱动的免疫逃逸进行了一些探索,但对其在CRC免疫治疗中的影响仍缺乏全面的概述。在本综述中,我们全面评估了lncRNA在与CRC相关的免疫逃逸机制中的作用,重点关注免疫检查点、免疫细胞和细胞因子。我们阐明了lncRNA介导的免疫逃逸与CRC进展之间的关系,并讨论了lncRNA介导的CRC免疫治疗策略。我们的目的是为靶向lncRNAs以提高CRC免疫治疗策略的有效性提供新的见解。